Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3278054 | 1.00 | ALDH1A1 (0.35) | ALDH1A1KDM4E | |
| SCHEMBL7421159 | 1.00 | ALDH1A1 (0.35) | ALDH1A1KDM4E | |
| SCHEMBL9640691 | 0.95 | — | — | |
| SCHEMBL9640680 | 0.95 | — | — | |
| SCHEMBL121087 | 0.95 | — | — | |
| SCHEMBL1200366 | 0.92 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL11825898 | 0.90 | KDM4E (0.33) | ALDH1A1KDM4E | |
| SCHEMBL1200265 | 0.90 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL7279427 | 0.90 | ALDH1A1 (0.39) | ALDH1A1KDM4E | |
| SCHEMBL1133414 | 0.87 | ALDH1A1 (0.38) | ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024140638-A1 | COMPOUND BASED ON SULFUR/OXYGEN SUBSTITUTED GLUTARIMIDE-BASED ISOINDOLINONE SKELETON AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-07-04 | — | — | WO | claimed |
| WO-2024140637-A1 | OXOISOINDOLINYL SUBSTITUTED PIPERIDINEDIONE DERIVATIVE AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-07-04 | — | — | WO | claimed |
| US-11926127-B2 | Window film for display device and display device including same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-03-12 | — | — | US | claimed |
| WO-2023151635-A1 | COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2023-08-17 | — | — | WO | claimed |
| WO-2023066350-A1 | CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS | 标新生物医药科技(上海)有限公司 | 2023-04-27 | — | — | WO | claimed |
| WO-2023030170-A1 | PROTEIN DEGRADATION COMPOUND BASED ON NAMPT TARGET PROTEIN AND APPLICATION THEREOF | 标新生物医药科技(上海)有限公司 | 2023-03-09 | — | — | WO | claimed |
| WO-2023284703-A1 | PROTEIN DEGRADATION COMPOUND DESIGNED ON THE BASIS OF BRUTON'S TYROSINE KINASE LIGAND AND APPLICATION THEREOF | 标新生物医药科技(上海)有限公司 | 2023-01-19 | — | — | WO | claimed |
| CN-110780014-B | Method for identifying gall-containing wood by gas chromatography-mass spectrometry technology | 莆田市家具产品质量监督检验中心 | 2022-07-19 | — | — | CN | claimed |
| US-20210016552-A1 | WINDOW FILM FOR DISPLAY DEVICE AND DISPLAY DEVICE INCLUDING SAME | SAMSUNG SDI CO., LTD. (KR) | 2021-01-21 | — | — | US | claimed |
| EP-3495343-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC Corporation (JP) | 2019-06-12 | — | — | EP | claimed |
| US-20190169502-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2019-06-06 | — | — | US | claimed |
| EP-3197511-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160006010-A1 | NEGATIVE ELECTRODE FOR SECONDARY BATTERY, METHOD FOR PRODUCING SAME, AND SECONDARY BATTERY USING SAME | NEC CORPORATION (JP) | 2016-01-07 | — | — | US | claimed |
| US-8673682-B2 | High order silane composition and method of manufacturing a film-coated substrate | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-03-18 | — | — | US | claimed |
| US-20030138471-A1 | Biorational repellents obtained from terpenoids for use against arthropods | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2003-07-24 | — | — | US | claimed |
| EP-0782571-A1 | COMPOSITIONS AND METHODS FOR TREATING MAST-CELL INFLAMMATORY CONDITION | ARRIS PHARMACEUTICAL CORPORATION (US) | 1997-07-09 | — | — | EP | claimed |
| WO-1996009297-A1 | COMPOSITIONS AND METHODS FOR TREATING MAST-CELL INFLAMMATORY CONDITION | ARRIS PHARMACEUTICAL CORPORATION (US) | 1996-03-28 | — | — | WO | claimed |
| US-4758615-A | Polymers containing urethane groups prepared by the reaction of polyamino compounds and cyclic carbonates | HOECHST AG (DE) | 1988-07-19 | — | — | US | claimed |
| US-4709047-A | CATALYSTS FOR CROSSLINKING OF UNSATURATED IMIDES | CIBA-GEIGY CORPORATION (US) | 1987-11-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169502-A1 | POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | PLD1, AP3D1, CCND1 | ALDH1A1 2853/4885KDM4E 2204/4885 |
| US-20030138471-A1 | Biorational repellents obtained from terpenoids for use against arthropods | MME, FNTA, ACE | ALDH1A1 716/4885KDM4E 2315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.